Purchases and Sales Made in Q3 2022 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q3 2022. The information is specifically focused on institutions that hold shares of NEUROCRINE BIOSCIENCES INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2022
Q3 2022
|
Td Asset Management Inc
|
SELL
|
- |
-95.7K- 41.01% |
$8.81M - $10.3M
|
138K
$18.4M
|
|
|
Nov 14, 2022
Q3 2022
|
Eaton Vance Management
Boston, MA |
SELL
|
- |
-122K- 8.29% |
$11.2M - $13.1M
|
1.35M
$180M
|
|
|
Nov 14, 2022
Q3 2022
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-129K- 10.91% |
$11.9M - $13.9M
|
1.05M
$140M
|
|
|
Nov 14, 2022
Q3 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-287K- 5.5% |
$26.4M - $30.9M
|
4.93M
$658M
|
|
|
Nov 14, 2022
Q3 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-298K- 74.85% |
$27.4M - $32.1M
|
100K
$13.4M
|
|
|
Oct 19, 2022
Q3 2022
|
Nordea Investment Management Ab
Stockholm, V7 |
SELL
|
- |
-358K- 94.69% |
$32.9M - $38.6M
|
20.1K
$2.68M
|
|
|
Nov 14, 2022
Q3 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-420K- 39.18% |
$38.6M - $45.3M
|
652K
$87M
|
|
|
Nov 14, 2022
Q3 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-500K- 24.84% |
$46M - $53.9M
|
1.51M
$202M
|
|
|
Nov 14, 2022
Q3 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-610K- 77.82% |
$56.2M - $65.8M
|
174K
$23.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-627K- 20.9% |
$57.7M - $67.5M
|
2.37M
$317M
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-2.49M- 63.01% |
$229M - $269M
|
1.46M
$195M
|